Hims & Hers Health (NYSE:HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s CEO, Andrew Dudum, disclosed the sale of more than $33M worth of company stock.
The transaction comes after the weight loss
Hims & Hers Health CEO discloses sale of over $33M worth of company stock
18 hours ago
1
Related
‘Hypocrisy noted’: Did Elon Musk’s own Grok just turn on him...
9 minutes ago
0
IEA warns of oversupplied oil market but says sanctions on R...
18 minutes ago
0
How CEOs deal with Trump: Praise, face time, remorse, and gi...
18 minutes ago
0
ITR Filing 2025: What precautions should you take while fili...
19 minutes ago
0
Biggest stock movers Wednesday: CRWV, INTA, and more
24 minutes ago
0
uCloudlink misses top-line estimates; initiates Q3 and updat...
29 minutes ago
0
Radhakishan Damani’s latest portfolio moves—What’s new?
32 minutes ago
0
Qudian Non-GAAP EPADS of $0.26, revenue of $0.49M
34 minutes ago
0
Tencent in charts: Double-digit revenue growth across all se...
44 minutes ago
0
Tencent Non-GAAP EPS of RMB 6.79, revenue of RMB 184.54B
52 minutes ago
0
Radha Kishan Damani’s latest portfolio moves — what’s new?
55 minutes ago
0
Apollo-managed funds to acquire Kelvion
1 hour ago
0
Stock index futures tick up after post CP rally
1 hour ago
0
Popular
عکس | ماه کامل بر فراز حرم امام حسین (ع)
3 days ago
5
English (US) · © FBT Company 2025. All rights are reserved